Hepatoprotective Effects of Aureobasidium pullulans Derived β 1,3–1,6 Glucans in a Murine Model of Non-alcoholic Steatohepatitis-Reference-Cited by-同舟云学术

Hepatoprotective Effects of Aureobasidium pullulans Derived β 1,3–1,6 Glucans in a Murine Model of Non-alcoholic Steatohepatitis

Published:2022-11 Issue:6 Volume:12 Page:1428-1437
ISSN:0973-6883
Container-title:Journal of Clinical and Experimental Hepatology
language:en
Short-container-title:Journal of Clinical and Experimental Hepatology

Author:

Ikewaki Nobunao,Levy Gary A.,Kurosawa Gene,Iwasaki Masaru,Dedeepiya Vidyasagar D.,Vaddi Suryaprakash,Senthilkumar Rajappa,Preethy Senthilkumar,Abraham Samuel J.K.^ORCID

Publisher

Elsevier BV

Subject

Hepatology

Reference29 articles.

1. Anti-fibrotic activity of Euglena gracilis and paramylon in a mouse model of non-alcoholic steatohepatitis;Nakashima;Food Sci Nutr,2018

2. Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH;Oniciu;PLoS One,2018

3. Therapies in non-alcoholic steatohepatitis (NASH);Oseini;Liver Int,2017

4. Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: a 1-year randomized control trial;Alam;Saudi J Gastroenterol,2016

5. Animal models are essential to biological research: issues and perspectives;Barré-Sinoussi;Future Sci OA,2015

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beneficial immune-modulatory effects of the N-163 strain of Aureobasidium pullulans-produced 1,3-1,6 Beta glucans in Duchenne muscular dystrophy: Results of an open-label, prospective, exploratory case-control clinical study;IBRO Neuroscience Reports;2023-12

2. Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced β-glucan;Scientific Reports;2023-10-09

3. Beneficial changes in the gut microbiome of patients with multiple sclerosis after consumption of Neu-REFIX B-glucan in a clinical trial;2023-09-08

4. Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD);Foods;2023-09-01

5. Gut mycobiome in metabolic diseases: Mechanisms and clinical implication;Biomedical Journal;2023-06